Evaluation of the relationship between arterial blood pressure, aortic stiffness and serum endothelin-1 levels in patients with essential hypertension

Clinical and Experimental Hypertension

Volumn 35, Issue 8, 2013, Pages 589-594

  Nar, Gokay ^a   Soylu, Korhan ^a   Akcay, Murat ^a   Gulel, Okan ^a   Yuksel, Serkan ^a   Meric, Murat ^a   Zengin, Halit ^a   Erbay, Aliriza ^a   Nar, Rukiye ^a   Demircan, Sabri ^a   Sahin, Mahmut ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Aortic stiffness; Endothelin 1; Essential hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL;

ADULT; AORTA; ARTERIAL PRESSURE; CASE-CONTROL STUDIES; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; VASCULAR STIFFNESS;

EID: 84887236750     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2013.776565     Document Type: Article

References (20)

1. Cohn JN. Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. Am J Hypertens 2001; 14(Suppl):258-263.
2. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J AmColl Cardiol 1993; 21:1145-1151. (Pubitemid 23106189)
3. Schiffrin EL, Deng LY, Sventek P, Day R. Enhanced expression of endothelin-1 gene in endothelium of resistance arteries in severe human essential hypertension. J Hypertens 1997; 15:57-63. (Pubitemid 27075987)
4. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241. (Pubitemid 34163575)
5. Stefanadis C, Dernellis J, Tsiamis E, et al. Aortic stiffness as a risk factor for recurrent acute coronary events in patients with ischaemic heart disease. Eur Heart J 2000; 21:390-396. (Pubitemid 30107556)
6. Seyfeli E,DuruM, SaglamH.Association of left ventricular diastolic function abnormalities with aortic elastic properties in asymptomatic patients with type 2 diabetes mellitus. A tissue doppler echocardiographic study. Int J Clin Pract 2008; 62:1358-1365.
7. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton, FL: CRC Press, 1990.
8. Ross RR. Atherosclerosis: an inflammatory disease.NEngl J Med 1999; 340:115-126.
9. Kinlay S, Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy.AmJCardiol 1997; 80:11I-16I. (Pubitemid 27490822)
10. Ergul S, Parish DC, Puett D, Ergul A. Racial difference in plasma endothelin-1 concentrations in individuals with essential hypertension. Hypertension 1996; 8:652-655. (Pubitemid 26327964)
11. Cardillo C, Kilcoyne CM, Waclav M, Cannon RoII I, Panza JA. Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 1999; 33:753-758. (Pubitemid 29091660)
12. Schneider M, Hilgers KF, Arnfried U, et al. Plasma endothelin is increased in early essential hypertension. Am J Hypertens 2000; 13:579-585. (Pubitemid 30459867)
13. Stefanadis C, Dernellis J, Vlachopoulos C, et al. Aortic function in arterial hypertension determined by pressure-diameter relation: effects of diltiazem. Circulation 1997; 96:1853-1858. (Pubitemid 27400744)
14. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries. Theoretical, Experimental and Clinical Principles, 4th ed. London: Arnold; 1998:418-476.
15. Blacher J, Asmar R, Djane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33:1111-1117. (Pubitemid 29230958)
16. Liao D, Arnett DK, Tyroler HA, et al. Arterial stiffness and the development of hypertension: the ARIC Study. Hypertension 1999; 34:201-206. (Pubitemid 29409215)
17. Benetos A, Adamopoulos C, Bureau JM, et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002; 105:1202-1207. (Pubitemid 34225821)
18. Vanhotte PM, Boulanger CM, Illiano SC, Nagao T, Yidal M, Mombouli JV. Endothelium dependent effects of converting enzyme inhibitors. J Cardiovasc Pharmacol 1993; 22 (Suppl 5):S10-S16.
19. Ciccone MM, Favale S, Scicchitano P, et al. Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients. Int J Cardiol 2012; 3:383-386.
20. Higashi Y, Sasaki S, Nakagawa K, et al. A comparison of angiotensin converting enzyme inhibitors, beta blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study. J Am Coll Cardiol 2000; 35:284-291. (Pubitemid 30125515)